Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults
- Status
- COMPLETED
- Phase
- PHASE3
A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176
- Status
- COMPLETED
- Phase
- PHASE1
The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients
- Status
- COMPLETED
- Phase
- N/A
This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama
- Status
- COMPLETED
- Phase
- NA
MMR and MMRV Vaccines: Effect of Age at First Dose on Safety and Immunogenicity of the Measles Component.
- Status
- UNKNOWN
- Phase
- N/A
Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization
- Status
- COMPLETED
- Phase
- N/A
A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.
- Status
- COMPLETED
- Phase
- PHASE2
A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE4
Study Investigating Efficacy of an Occluding Dentifrice for Dentine Hypersensitivity
- Status
- COMPLETED
- Phase
- NA
Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tablets in Chinese Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.
- Status
- COMPLETED
- Phase
- PHASE3
Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1